Clinical Trials

Sponsor: BioAtla, LLC

Sponsor Study ID: BA3011-002

Study Title: A Phase 2 Study of BA3011 Alone and in Combination with Nivolumab in Adult Patients with Metastatic Non Small Cell Lung Cancer (NSCLC) Who Had Prior Disease Progression on a PD 1/L 1 Inhibitor, EGFR, or ALK Inhibitor

NCT Number: NCT04681131

Phase: II

Protocol Type: Treatment

Age Group: Adult

Disease Sites: Lung

Study Objectives: To assess antitumor activity of BA3011 alone and in combination with nivolumab. To assess the safety of BA3011 alone and in combination with nivolumab.



For more information about the trial above please contact the study team:

Trial opened at the following institutions: Medical University of South Carolina

Study Documents
(MUSC NetID required for document access)